Baptiste Gérard, Florian Bailly & Anne-Priscille Trouvin. (2024) How to treat chronic pain in rheumatic and musculoskeletal diseases (RMDs) – A pharmacological review. Joint Bone Spine 91:1, pages 105624.
Crossref
Éva Borbély, Angéla Kecskés, József Kun, Eszter Kepe, Barbara Fülöp, Katalin Kovács-Rozmer, Bálint Scheich, Éva Renner, Miklós Palkovits & Zsuzsanna Helyes. (2023) Hemokinin-1 is a mediator of chronic restraint stress-induced pain. Scientific Reports 13:1.
Crossref
Yukinori Nagakura, Maya Hayashi & Shunichi Kajioka. (2023) Analysis of Japanese nationwide health datasets: association between lifestyle habits and prevalence of neuropathic pain and fibromyalgia with reference to dementia-related diseases and Parkinson’s disease. Scandinavian Journal of Pain 23:4, pages 662-669.
Crossref
Kacper Bułdyś, Tomasz Górnicki, Dariusz Kałka, Ewa Szuster, Małgorzata Biernikiewicz, Leszek Markuszewski & Małgorzata Sobieszczańska. (2023) What Do We Know about Nociplastic Pain?. Healthcare 11:12, pages 1794.
Crossref
Octavian Vasiliu. (2023) Efficacy, Tolerability, and Safety of Toludesvenlafaxine for the Treatment of Major Depressive Disorder—A Narrative Review. Pharmaceuticals 16:3, pages 411.
Crossref
Yian Chen, Eric Wang, Brian D Sites & Steven P Cohen. (2023) Integrating mechanistic-based and classification-based concepts into perioperative pain management: an educational guide for acute pain physicians. Regional Anesthesia & Pain Medicine, pages rapm-2022-104203.
Crossref
Felipe Araya-Quintanilla, Héctor Gutiérrez-Espinoza, Jorge Fuentes, Fernanda Prieto-Lafrentz, Leonardo Pavez, Carlos Cristi-Montero, Iván Cavero-Redondo & Celia Álvarez-Bueno. (2022) Effectiveness of multicomponent treatment in patients with fibromyalgia: protocol for a systematic review and meta-analysis. Systematic Reviews 11:1.
Crossref
Beltrán Álvarez-Pérez, Anna Bagó-Mas, Meritxell Deulofeu, José Miguel Vela, Manuel Merlos, Enrique Verdú & Pere Boadas-Vaello. (2022) Long-Lasting Nociplastic Pain Modulation by Repeated Administration of Sigma-1 Receptor Antagonist BD1063 in Fibromyalgia-like Mouse Models. International Journal of Molecular Sciences 23:19, pages 11933.
Crossref
Liraz Cohen-Biton, Dan Buskila & Rachel Nissanholtz-Gannot. (2022) Review of Fibromyalgia (FM) Syndrome Treatments. International Journal of Environmental Research and Public Health 19:19, pages 12106.
Crossref
Anthony D. Ong, Judith T. Moskowitz, Elaine Wethington, Elizabeth L. Addington, Mubarak Sanni, Selin Goktas, Erica Sluys, Sarah Swong, Patricia Kim & M. Carrington Reid. (2022) Lessons in Affect Regulation to Keep Stress and Pain UndeR control (LARKSPUR): Design of a randomized controlled trial to increase positive affect in middle-aged and older adults with fibromyalgia. Contemporary Clinical Trials 120, pages 106880.
Crossref
Levent HACISÜLEYMAN, Bülent SARAÇ & Ziad JOHA. (2022) Analgesic Effects of Vilazodone, Indatraline, and Talsupram in a Rat Model of Neuropathic Pain. Turkish Journal of Pharmaceutical Sciences 19:3, pages 336-342.
Crossref
Beltrán Álvarez-Pérez, Meritxell Deulofeu, Judit Homs, Manuel Merlos, José Miguel Vela, Enrique Verdú & Pere Boadas-Vaello. (2022) Long-lasting reflexive and nonreflexive pain responses in two mouse models of fibromyalgia-like condition. Scientific Reports 12:1.
Crossref
Jozélio Freire de Carvalho & Thelma L Skare. (2022) Lidocaine in fibromyalgia: A systematic review. World Journal of Psychiatry 12:4, pages 615-622.
Crossref
Jalal Doufik, Hicham Laaraj, Mina Ouhmou, Omar El Oumary, Khalid Mouhadi & Ismail Rammouz. (2022) Au-delà de la dépression, des antidépresseurs pour traiter la douleur chronique. Annales Médico-psychologiques, revue psychiatrique 180:2, pages 141-144.
Crossref
Devant GoswamiDr.Dr., Surinder Singh SodhiDrDrNalin VilochanDrDrRikki DeswalDr.Dr.. (2022) FIBROMYALGIA: PRESENT AND FUTURE! WHERE WE STAND. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 40-44.
Crossref
Miguel Astráin -E. García Recio, J. de Santiago -M. Sánchez -. (2022) ¿Es útil el cannabis medicinal para el tratamiento de la fibromialgia?. Revista de la Sociedad Española del Dolor.
Crossref
Yasser El Miedany. 2022. Advances in Chronic and Neuropathic Pain. Advances in Chronic and Neuropathic Pain
201
239
.
Aniqa G Qureshi, Saurav K Jha, John Iskander, Chaithanya Avanthika, Sharan Jhaveri, Vithi Hitendra Patel, Bhuvana Rasagna Potini & Ahmad Talha Azam. (2021) Diagnostic Challenges and Management of Fibromyalgia. Cureus.
Crossref
Harshit Gupta, Brook Girma, Jack S. Jenkins, Sarah E. Kaufman, Christopher A. Lee & Alan D. Kaye. (2021) Milnacipran for the Treatment of Fibromyalgia. Health Psychology Research 9:1.
Crossref
Hiroyasu Murasawa, Akiko Pawlak, Hiroyuki Kobayashi, Kensuke Saeki, Shun-ichi Yasuda & Yutaka Kitano. (2021) Mirogabalin, a novel ligand for α2δ subunit of voltage-gated calcium channels, improves cognitive impairments in repeated intramuscular acidic saline injection model rats, an experimental model of fibromyalgia. Biomedicine & Pharmacotherapy 139, pages 111647.
Crossref
Maya Levy Coles & Yosef Uziel. (2021) Juvenile primary fibromyalgia syndrome: A Review- Treatment and Prognosis. Pediatric Rheumatology 19:1.
Crossref
Mary-Ann Fitzcharles, Steven P Cohen, Daniel J Clauw, Geoffrey Littlejohn, Chie Usui & Winfried Häuser. (2021) Nociplastic pain: towards an understanding of prevalent pain conditions. The Lancet 397:10289, pages 2098-2110.
Crossref
Henry Jair Mayorga Anaya, María Paula Torres Ortiz, Daniel Hernando Flórez Valencia & Omar Fernando Gomezese Ribero. (2021) Efficacy of cannabinoids in fibromyalgia: a literature review. Colombian Journal of Anesthesiology.
Crossref
Vishwas Tripathi, Amaresh Mishra, Yamini Pathak, Aklank Jain & Hridayesh Prakash. 2021. Macrophages. Macrophages.
Emma Guymer & Geoffrey Littlejohn. 2021. Fibromyalgia Syndrome. Fibromyalgia Syndrome
33
52
.
Douglas O. Escrivani, Gabriela C. Mattos, Bartira Rossi-Bergmann & Ariane J. Sousa-Batista. 2022. Antiprotozoal Drug Development and Delivery. Antiprotozoal Drug Development and Delivery
181
217
.
Yen-Feng Wang, Yung-Tai Chen, Ching-Wen Tsai, Yu-Chun Yen, Yi-Chun Chen, Ben-Chang Shia & Shuu-Jiun Wang. (2020) Persistence of pregabalin treatment in Taiwan: a nation-wide population-based study. The Journal of Headache and Pain 21:1.
Crossref
Andrea R. Pfalzgraf, Carroline P. Lobo, Vincent Giannetti & Kimberly Dupree Jones. (2020) Use of Complementary and Alternative Medicine in Fibromyalgia: Results of an Online Survey. Pain Management Nursing 21:6, pages 516-522.
Crossref
Piercarlo Sarzi-Puttini, Valeria Giorgi, Daniela Marotto & Fabiola Atzeni. (2020) Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nature Reviews Rheumatology 16:11, pages 645-660.
Crossref
Massimo E. Maffei. (2020) Fibromyalgia: Recent Advances in Diagnosis, Classification, Pharmacotherapy and Alternative Remedies. International Journal of Molecular Sciences 21:21, pages 7877.
Crossref
Hirofumi Hirakawa, Takeshi Terao & Nobuyoshi Ishii. (2020) A Case of Facial Pain in Somatic Symptom Disorder Responding to Duloxetine. Journal of Clinical Psychopharmacology 40:5, pages 512-513.
Crossref
Hiroyasu Murasawa, Hiroyuki Kobayashi, Shun-ichi Yasuda, Kensuke Saeki, Yuki Domon, Naohisa Arakawa, Kazufumi Kubota & Yutaka Kitano. (2020) Anxiolytic-like effects of mirogabalin, a novel ligand for α2δ ligand of voltage-gated calcium channels, in rats repeatedly injected with acidic saline intramuscularly, as an experimental model of fibromyalgia. Pharmacological Reports 72:3, pages 571-579.
Crossref
Alfonso Javier Ibáñez-Vera, Jerónimo Carmelo García-Romero, José Ramón Alvero-Cruz & Rafael Lomas-Vega. (2020) Effects of Monopolar Dielectric Radiofrequency Signals on the Symptoms of Fibromyalgia: A Single-Blind Randomized Controlled Trial. International Journal of Environmental Research and Public Health 17:7, pages 2465.
Crossref
Vittorio Schweiger, Erica Secchettin, Cinzia Castellani, Alvise Martini, Elena Mazzocchi, Alessandro Picelli, Enrico Polati, Katia Donadello, Maria Teresa Valenti & Luca Dalle Carbonare. (2020) Comparison between Acupuncture and Nutraceutical Treatment with Migratens® in Patients with Fibromyalgia Syndrome: A Prospective Randomized Clinical Trial. Nutrients 12:3, pages 821.
Crossref
Roie Tzadok & Jacob N. Ablin. (2020) Current and Emerging Pharmacotherapy for Fibromyalgia. Pain Research and Management 2020, pages 1-9.
Crossref
Samir Kumar Praharaj & Chittaranjan Andrade. 2020. Mental Health and Illness in the Rural World. Mental Health and Illness in the Rural World
327
364
.
Mohammad Jafferany, Bárbara Roque Ferreira & Arsh PatelArsh Patel, Mohammad Jafferany & Bárbara Roque Ferreira. 2020. The Essentials of Psychodermatology. The Essentials of Psychodermatology
83
89
.
Amna Shaikh & Sarah Money. (2019) Cannabinoids and Pain Management: an Insight into Recent Advancements. Current Emergency and Hospital Medicine Reports 7:4, pages 208-213.
Crossref
Chun-Jen Huang, Chin-Liang Huang, Yen-Chun Fan, Ting-Yu Chen & Pei-Shan Tsai. (2019) Insomnia Increases Symptom Severity and Health Care Utilization in Patients With Fibromyalgia. The Clinical Journal of Pain 35:9, pages 780-785.
Crossref
Filipa Raposo Pereira, Paul Zhutovsky, Minni T.B. Mcmaster, Nikki Polderman, Yvon D.A.T. de Vries, Wim van den Brink & Guido A. van Wingen. (2019) Recreational use of GHB is associated with alterations of resting state functional connectivity of the central executive and default mode networks. Human Brain Mapping 40:8, pages 2413-2421.
Crossref
Thitiporn Supasitthumrong, Blanca M. Bolea‐Alamanac, Selim Asmer, Vincent L. Woo, Petal S. Abdool & Simon J.C. Davies. (2019) Gabapentin and pregabalin to treat aggressivity in dementia: a systematic review and illustrative case report. British Journal of Clinical Pharmacology 85:4, pages 690-703.
Crossref
Tine van de Donk, Marieke Niesters, Mikael A. Kowal, Erik Olofsen, Albert Dahan & Monique van Velzen. (2018) An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia. Pain 160:4, pages 860-869.
Crossref
Ken-ichiro Hayashida & Hideaki Obata. (2019) Strategies to Treat Chronic Pain and Strengthen Impaired Descending Noradrenergic Inhibitory System. International Journal of Molecular Sciences 20:4, pages 822.
Crossref
Mohammad Jafferany & Maryam E. Davari. (2018) Itch and psyche: psychiatric aspects of pruritus. International Journal of Dermatology 58:1, pages 3-23.
Crossref
Aniket Roy, Rahul Dixit, Ruchira Naskar & Rajat Subhra ChakrabortySamir Kumar Praharaj & Chittaranjan Andrade. 2020. Digital Image Forensics. Digital Image Forensics
1
38
.
Joelle Thorpe, Bonnie Shum, R Andrew Moore, Philip J Wiffen & Ian Gilron. (2018) Combination pharmacotherapy for the treatment of fibromyalgia in adults. Cochrane Database of Systematic Reviews 2020:10.
Crossref
Bernard Mazières. 2018. Rhumatologie pour le Praticien. Rhumatologie pour le Praticien
425
436
.
Hideaki Obata. (2017) Analgesic Mechanisms of Antidepressants for Neuropathic Pain. International Journal of Molecular Sciences 18:11, pages 2483.
Crossref
Francisco Buitrago Ramírez, Manuel Tejero Mas, Cristina Gato Núñez, Nuria Rivera Jiménez & Francisco Luis Pérez Caballero. (2017) Abordaje integrado de la fibromialgia. FMC - Formación Médica Continuada en Atención Primaria 24:7, pages 395-404.
Crossref
Sabrina Gmuca & David D. Sherry. (2017) Fibromyalgia: Treating Pain in the Juvenile Patient. Pediatric Drugs 19:4, pages 325-338.
Crossref
Tejs Jansen, Henrik Petersen, Cecilie M. Malskaer, Charlotte Gabel-Jensen, Kim Dalhoff, Thomas Eriksen, Bo Belhage & Lotte C. G. Hoegberg. (2017) Activated Charcoal Haemoperfusion in the Treatment of Experimental Amitriptyline Poisoning in Pigs - The Effect on Amitriptyline Plasma Concentration and Haemodynamic Parameters. Basic & Clinical Pharmacology & Toxicology 120:5, pages 491-497.
Crossref
Kevin A. Wang, Jia-Chi Wang, Cheng-Li Lin & Chun-Hung Tseng. (2017) Association between fibromyalgia syndrome and peptic ulcer disease development. PLOS ONE 12:4, pages e0175370.
Crossref
Jesus Castro-Marrero, Naia Sáez-Francàs, Dafna Santillo & Jose Alegre. (2017) Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome. British Journal of Pharmacology 174:5, pages 345-369.
Crossref
Yu Mi Ju, Sang Ho Shin, Shu Chung Choi, Jin Young Chon, Choon Ho Sung & Ho Sik Moon. (2017) Implantable drug delivery systems with morphine in fibromyalgia -A case report-. Anesthesia and Pain Medicine 12:1, pages 91-94.
Crossref
Caroline A. Arout, Mehmet Sofuoglu & Robert A. Rosenheck. (2017) Rates and Correlates of Pain Specialty Clinic Use Nationally in the Veterans Health Administration. Pain Medicine, pages pnw206.
Crossref
Elena P Calandre, Fernando Rico-Villademoros & Mahmoud Slim. (2017) Pharmacological treatment of fibromyalgia: is the glass half empty or half full?. Pain Management 7:1, pages 5-10.
Crossref
Eiad A. Ramzy. (2017) Comparative Efficacy of Newer Antidepressants in Combination with Pregabalin for Fibromyalgia Syndrome: A Controlled, Randomized Study. Pain Practice 17:1, pages 32-40.
Crossref
Hans-Peter Kapfhammer. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
2105
2253
.
Douglas D. Richman, Richard J. Whitley & Frederick J. HaydenAndrew R. Lloyd. 2016. Clinical Virology. Clinical Virology
371
384
.
Daniel Whibley, Linda E. Dean & Neil Basu. (2016) Management of Widespread Pain and Fibromyalgia. Current Treatment Options in Rheumatology 2:4, pages 312-320.
Crossref
Ilaria Sanzarello, Luciano Merlini, Michele Attilio Rosa, Mariada Perrone, Jacopo Frugiuele, Raffaele Borghi & Cesare Faldini. (2016) Central sensitization in chronic low back pain: A narrative review. Journal of Back and Musculoskeletal Rehabilitation 29:4, pages 625-633.
Crossref
Robert M Bennett. (2016) Pain management in fibromyalgia. Pain Management 6:4, pages 313-316.
Crossref
Young Ho Lee & Gwan Gyu Song. (2016) Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials. Rheumatology International 36:5, pages 663-672.
Crossref
Steven Chinn, William Caldwell & Karina Gritsenko. (2016) Fibromyalgia Pathogenesis and Treatment Options Update. Current Pain and Headache Reports 20:4.
Crossref
Hans-Peter Kapfhammer. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1
155
.
Mehmet Uçar, Ümit Sarp, Özgül Karaaslan, Ali Irfan Gül, Nermin Tanik & Hasan Onur Arik. (2015) Health anxiety and depression in patients with fibromyalgia syndrome. Journal of International Medical Research 43:5, pages 679-685.
Crossref
Anthony Ong, Judith T. Moskowitz, Elaine Wethington, Elizabeth L. Addington, Mubark Sanni, Selin Goktas, Erica Sluys, Sarah Swong, Patricia Kim & M. Carrington Reid. (2022) Lessons in Affect Regulation to Keep Stress and Pain Under Control (LARKSPUR) Protocol for a Randomized Pilot Trial to Promote Positive Affect in Adults with Fibromyalgia. SSRN Electronic Journal.
Crossref